Suppr超能文献

CD44剪接变体在恶性和良性胸腔积液中的差异表达。

Differential expression of CD44 splice variants in malignant and benign pleural effusions.

作者信息

Tojo N, Inase N, Ichioka M, Miyazato I, Nara N

机构信息

Department of Laboratory Medicine, Faculty of Medicine, Tokyo Medical and Dental University, Japan.

出版信息

Tohoku J Exp Med. 1996 Aug;179(4):273-9. doi: 10.1620/tjem.179.273.

Abstract

Expression of CD44 isoform that contains variant exons (v1-v10) has been implicated in tumor progression and metastasis. Especially, CD44 isoform containing v6 (CD44v6) and that containing v7 (CD44v7) were shown to confer full metastatic behavior on tumor cells. We examined the expression of CD44v6 and CD44v7 in malignant pleural effusions (13 lung cancers and 4 non-lung cancers) and in benign pleural effusions (7 tuberculosis and 3 pneumonia) with Southern blot analysis of reverse transcription (RT)-polymerase chain reaction (PCR) products. CD44v6 was expressed not only in malignant pleural effusions (12 of 13 lung cancers and 4 of 4 non-lung cancers), but also in benign pleural effusions(9/10). In contrast, although expression of CD44v7 was found in most malignant pleural effusions (12 of 13 lung cancers and 4 of 4 non-lung cancers), it was found in only a few cases of benign pleural effusions. These results suggest that the expression of CD44v7 may be correlated with a tumor-specific event such as metastasis or dissemination in malignant pleural effusion, while no such correlation can be found with CD44v6.

摘要

包含可变外显子(v1-v10)的CD44异构体的表达与肿瘤进展和转移有关。特别是,含有v6的CD44异构体(CD44v6)和含有v7的CD44异构体(CD44v7)已被证明赋予肿瘤细胞完全的转移行为。我们通过对逆转录(RT)-聚合酶链反应(PCR)产物进行Southern印迹分析,检测了恶性胸腔积液(13例肺癌和4例非肺癌)和良性胸腔积液(7例肺结核和3例肺炎)中CD44v6和CD44v7的表达。CD44v6不仅在恶性胸腔积液中表达(13例肺癌中有12例,4例非肺癌中有4例),也在良性胸腔积液中表达(10例中有9例)。相比之下,虽然在大多数恶性胸腔积液中发现了CD44v7的表达(13例肺癌中有12例,4例非肺癌中有4例),但仅在少数良性胸腔积液病例中发现。这些结果表明,CD44v7的表达可能与恶性胸腔积液中的转移或播散等肿瘤特异性事件相关,而CD44v6则未发现此类相关性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验